Karius
Dr. Blauwkamp, a co-founder of Karius, is a biomedical scientist with 15 years experience managing and conducting research in molecular biology, regenerative medicine, and next-generation sequencing. He was previously Head of Molecular Biology at Moleculo, where he ran scientific research and lab operations until the company’s acquisition by Illumina. He continued to lead a technology development group within Illumina, creating new genomics tools and authoring several patent applications.
This person is not in any offices
Karius
2 followers
Karius sees a world where infectious disease is no longer a major threat to human health. To achieve this, the Karius Test enables mapping of the patient’s microbial landscape from a single blood sample to enable physicians to make rapid treatment decisions.